デフォルト表紙
市場調査レポート
商品コード
1612996

臨床化学分析装置市場:検査、製品、エンドユーザー別-2025-2030年の世界予測

Clinical Chemistry Analyzer Market by Test (Basic Metabolic Panel, Electrolyte Panel, Lipid Profile), Product (Analyzer, Reagent), End User - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 198 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.26円
臨床化学分析装置市場:検査、製品、エンドユーザー別-2025-2030年の世界予測
出版日: 2024年12月01日
発行: 360iResearch
ページ情報: 英文 198 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床化学分析装置市場は、2023年に121億米ドルと評価され、2024年には127億6,000万米ドルに達すると予測され、CAGR 5.64%で成長し、2030年には177億8,000万米ドルになると予測されています。

臨床化学分析装置は、血漿や血清を分析し、酵素値、血糖値、タンパク質、電解質などの検査を行うために使用される重要な検査機器です。これらの分析装置は診断ラボ、病院、診療所に不可欠であり、疾病診断、治療モニタリング、臨床研究に不可欠なサポートを提供しています。これらの分析装置の必要性は、糖尿病や心疾患のような慢性疾患の蔓延が拡大しており、高度な診断とモニタリング・ソリューションが必要とされていることからも明らかです。最終用途の範囲は、個別化医療を推進する大規模検査施設、小規模POC(Point-of-Care)検査プラットフォーム、在宅医療サービスなど、さまざまな環境に広がっています。

主な市場の統計
基準年[2023] 121億米ドル
予測年[2024] 127億6,000万米ドル
予測年[2030] 177億8,000万米ドル
CAGR(%) 5.64%

市場に影響を与える主な成長要因には、データ分析強化のためのAIや機械学習との統合などの技術的進歩や、健康意識の高まりに後押しされたヘルスケア支出の増加が含まれます。また、自動化・小型化された機器の開発は、分散化された環境においてより迅速で正確な結果を求める需要に対応し、潜在的な機会をもたらします。積極的なアプローチを推奨する市場プレイヤーは、革新的な製品開拓、戦略的パートナーシップ、新興国市場への浸透に投資し、成長機会をつかむべきです。

しかし、先進的な分析装置の高価格や厳しい規制要件などの制約が課題となっており、新技術を既存システムに統合する際の複雑な相互運用性の問題もあります。技術革新という点では、市場は自動化の進展に適しており、人的介入や起こりうるエラーを減らしながら、業務効率を高めることができます。また、アプリケーションの範囲を広げ、アクセシビリティを向上させるために、ポータブルでユーザーフレンドリーなデバイスを開発することも有望な分野です。

臨床化学分析装置市場は、急速な技術進化と熾烈な競争を特徴としており、市場での地位を維持するためには絶え間ない警戒と革新が必要です。企業は研究開発投資に注力し、AIと機械学習機能を活用して優位に立つべきです。精密医療の需要が高まる中、規制状況をうまく乗り切り、コスト効率よく最先端技術を活用する企業は大きな利益を得ることができます。

市場力学:急速に進化する臨床化学分析装置市場の主要市場インサイトを公開

臨床化学分析装置市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 高齢者人口の増加と慢性疾患の蔓延
    • 世界のヘルスケア支出の増加
    • ポイントオブケア検査の重要性と認知度の高まり
  • 市場抑制要因
    • 高度な分析装置の高コスト
  • 市場機会
    • 臨床化学分析装置における継続的な技術進歩
    • 予測分析と予防医療への注目の高まり
  • 市場の課題
    • 厳しく多様な規制基準、訓練を受けた有資格の専門家の不足

ポーターのファイブフォース:臨床化学分析装置市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:臨床化学分析装置市場における外部からの影響の把握

外部マクロ環境要因は、臨床化学分析装置市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析臨床化学分析装置市場における競合情勢の把握

臨床化学分析装置市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス臨床化学分析装置市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、臨床化学分析装置市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨臨床化学分析装置市場における成功への道筋を描く

臨床化学分析装置市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 高齢者人口の増加と慢性疾患の増加
      • 世界のヘルスケア費の増加
      • ポイントオブケア検査の重要性と認識の高まり
    • 抑制要因
      • 高度な分析装置の高コスト
    • 機会
      • 臨床化学分析装置における継続的な技術進歩
      • 予測分析と予防医学への注目が高まる
    • 課題
      • 厳格で多様な規制基準と訓練を受けた有資格の専門家の不足
  • 市場セグメンテーション分析
    • テスト:慢性疾患モニタリングのための基礎代謝パネルの需要増加
    • 製品:大規模病院やリファレンスラボでの高スループット分析装置の導入が増加
    • エンドユーザー:患者の診断と管理をサポートする臨床化学分析装置の使用が増加
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 臨床化学分析装置市場テスト別

  • 基礎代謝パネル
  • 電解質パネル
  • 脂質プロファイル
  • 肝臓パネル
  • 腎臓プロファイル
  • 特殊化学品
  • 甲状腺機能パネル

第7章 臨床化学分析装置市場:製品別

  • アナライザ
    • 大規模(1200~2000テスト/時間)
    • 中(800~1200テスト/時間)
    • 小規模(400~800テスト/時間)
    • 非常に大きい(2000テスト/時間)
  • 試薬
    • キャリブレーター
    • コントロール
    • 標準

第8章 臨床化学分析装置市場:エンドユーザー別

  • 学術調査機関
  • 診断研究所
  • 病院

第9章 南北アメリカの臨床化学分析装置市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の臨床化学分析装置市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの臨床化学分析装置市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • ベックマン・コールター、DxC 500 AU化学分析装置のFDA認可を取得、実績あるシックスシグマ性能でポートフォリオを拡大
    • シーメンスヘルシナーズ、免疫測定検査用アテリカ CIアナライザーを発売
    • ErbaがMedlab中東でXLシリーズの全自動臨床化学システムを発表2023
  • 戦略分析と提言

企業一覧

  • Abbott Laboratories
  • Beckman Coulter, Inc. by Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • BioSystems Diagnostics Pvt. Ltd
  • Cardinal Health, Inc
  • Carolina Liquid Chemistries Corp.
  • Chengdu Seamaty Technology Co., Ltd.
  • DiaSys Diagnostic Systems GmbH
  • ELITechGroup
  • Erba Group
  • F. Hoffmann-La Roche Ltd.
  • Furuno Electric Co., Ltd.
  • Horiba, Ltd.
  • JEOL Ltd.
  • Johnson & Johnson Services, Inc.
  • Medica Corporation
  • Medsource Ozone Biomedicals Pvt. Ltd.
  • Mindray Medical International Limited
  • Nova Biomedical Corporation
  • Olympus Corporation
  • Promea Therapeutics Pvt. Ltd.
  • Randox Laboratories Ltd.
  • Siemens AG
  • Thermo Fisher Scientific, Inc.
  • Trivitron Healthcare
図表

LIST OF FIGURES

  • FIGURE 1. CLINICAL CHEMISTRY ANALYZER MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL CHEMISTRY ANALYZER MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CLINICAL CHEMISTRY ANALYZER MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CLINICAL CHEMISTRY ANALYZER MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL CHEMISTRY ANALYZER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLINICAL CHEMISTRY ANALYZER MARKET DYNAMICS
  • TABLE 7. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY BASIC METABOLIC PANEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ELECTROLYTE PANEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY LIPID PROFILE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY LIVER PANEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY RENAL PROFILE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY SPECIALTY CHEMICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY THYROID FUNCTION PANEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY LARGE (1200-2000 TESTS/H), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY MEDIUM (800-1200 TESTS/H), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY SMALL (400-800 TEST/H), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY VERY LARGE (2000 TESTS/H), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY CALIBRATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY STANDARDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY ANALYZER, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM CLINICAL CHEMISTRY ANALYZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 240. CLINICAL CHEMISTRY ANALYZER MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 241. CLINICAL CHEMISTRY ANALYZER MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-4311CE1A33A2

The Clinical Chemistry Analyzer Market was valued at USD 12.10 billion in 2023, expected to reach USD 12.76 billion in 2024, and is projected to grow at a CAGR of 5.64%, to USD 17.78 billion by 2030.

A Clinical Chemistry Analyzer is a vital piece of laboratory equipment used to analyze plasma or serum and perform tests such as enzyme levels, blood sugar, proteins, and electrolytes. These analyzers are integral to diagnostic labs, hospitals, and clinics, providing essential support for disease diagnosis, treatment monitoring, and clinical research. The necessity of these analyzers is underscored by the growing prevalence of chronic illnesses such as diabetes and cardiac disorders, necessitating advanced diagnostics and monitoring solutions. The end-use scope extends across various settings, including large laboratory facilities, small POC (Point-of-Care) testing platforms, and home healthcare services, driven by a push towards personalized medicine.

KEY MARKET STATISTICS
Base Year [2023] USD 12.10 billion
Estimated Year [2024] USD 12.76 billion
Forecast Year [2030] USD 17.78 billion
CAGR (%) 5.64%

Key growth factors influencing the market include technological advancements-such as integration with AI and machine learning for enhanced data analysis-and increasing healthcare expenditure, fueled by rising health awareness. The development of automated and miniaturized instruments also presents potential opportunities, catering to the demand for faster and more accurate results in decentralized settings. Recommending a proactive approach, market players should invest in innovative product development, strategic partnerships, and emerging market penetration to seize growth opportunities.

However, limitations such as high costs of advanced analyzers and stringent regulatory requirements pose challenges, alongside issues of complex interoperability in integrating new technologies with existing systems. In terms of innovation, the market is ripe for advancements in automation, reducing human intervention and possible errors while enhancing operational efficiency. Another promising area lies in developing portable, user-friendly devices to expand application scopes and improve accessibility.

The clinical chemistry analyzer market is characterized by rapid technological evolution and intense competition, requiring constant vigilance and innovation to maintain market position. Businesses should focus on R&D investments and leverage AI and machine-learning capabilities to stay ahead. As the demand for precision medicine rises, firms that successfully navigate regulatory landscapes and cost-effectively harness cutting-edge technology stand to gain significantly.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Chemistry Analyzer Market

The Clinical Chemistry Analyzer Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising elderly population and growing prevalence of chronic diseases
    • Increase in healthcare expenditure globally
    • Growing importance and awareness of point-of-care testing
  • Market Restraints
    • High cost of advanced analyzers
  • Market Opportunities
    • Ongoing technological advancements in clinical chemistry analyzer
    • Increasing focus on predictive analytics and preventative medicine
  • Market Challenges
    • Stringent and varying regulatory standards and a lack of trained and qualified professionals

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Chemistry Analyzer Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Chemistry Analyzer Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Chemistry Analyzer Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Chemistry Analyzer Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Chemistry Analyzer Market

A detailed market share analysis in the Clinical Chemistry Analyzer Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Chemistry Analyzer Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Chemistry Analyzer Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Clinical Chemistry Analyzer Market

A strategic analysis of the Clinical Chemistry Analyzer Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Clinical Chemistry Analyzer Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Beckman Coulter, Inc. by Danaher Corporation, Bio-Rad Laboratories, Inc., BioSystems Diagnostics Pvt. Ltd, Cardinal Health, Inc, Carolina Liquid Chemistries Corp., Chengdu Seamaty Technology Co., Ltd., DiaSys Diagnostic Systems GmbH, ELITechGroup, Erba Group, F. Hoffmann-La Roche Ltd., Furuno Electric Co., Ltd., Horiba, Ltd., JEOL Ltd., Johnson & Johnson Services, Inc., Medica Corporation, Medsource Ozone Biomedicals Pvt. Ltd., Mindray Medical International Limited, Nova Biomedical Corporation, Olympus Corporation, Promea Therapeutics Pvt. Ltd., Randox Laboratories Ltd., Siemens AG, Thermo Fisher Scientific, Inc., and Trivitron Healthcare.

Market Segmentation & Coverage

This research report categorizes the Clinical Chemistry Analyzer Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Test, market is studied across Basic Metabolic Panel, Electrolyte Panel, Lipid Profile, Liver Panel, Renal Profile, Specialty Chemicals, and Thyroid Function Panel.
  • Based on Product, market is studied across Analyzer and Reagent. The Analyzer is further studied across Large (1200-2000 Tests/H), Medium (800-1200 Tests/H), Small (400-800 Test/H), and Very Large (2000 Tests/H). The Reagent is further studied across Calibrator, Control, and Standards.
  • Based on End User, market is studied across Academic Research Institutes, Diagnostics Laboratories, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising elderly population and growing prevalence of chronic diseases
      • 5.1.1.2. Increase in healthcare expenditure globally
      • 5.1.1.3. Growing importance and awareness of point-of-care testing
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced analyzers
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technological advancements in clinical chemistry analyzer
      • 5.1.3.2. Increasing focus on predictive analytics and preventative medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent and varying regulatory standards and a lack of trained and qualified professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Test: Growing demand for basic metabolic panel for chronic conditions monitoring
    • 5.2.2. Product: Growing adoption of high-throughput analyzers across large hospitals and reference labs
    • 5.2.3. End User: Growing use of clinical chemistry analyzers to support patient diagnostics and management
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clinical Chemistry Analyzer Market, by Test

  • 6.1. Introduction
  • 6.2. Basic Metabolic Panel
  • 6.3. Electrolyte Panel
  • 6.4. Lipid Profile
  • 6.5. Liver Panel
  • 6.6. Renal Profile
  • 6.7. Specialty Chemicals
  • 6.8. Thyroid Function Panel

7. Clinical Chemistry Analyzer Market, by Product

  • 7.1. Introduction
  • 7.2. Analyzer
    • 7.2.1. Large (1200-2000 Tests/H)
    • 7.2.2. Medium (800-1200 Tests/H)
    • 7.2.3. Small (400-800 Test/H)
    • 7.2.4. Very Large (2000 Tests/H)
  • 7.3. Reagent
    • 7.3.1. Calibrator
    • 7.3.2. Control
    • 7.3.3. Standards

8. Clinical Chemistry Analyzer Market, by End User

  • 8.1. Introduction
  • 8.2. Academic Research Institutes
  • 8.3. Diagnostics Laboratories
  • 8.4. Hospitals

9. Americas Clinical Chemistry Analyzer Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Clinical Chemistry Analyzer Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Clinical Chemistry Analyzer Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Beckman Coulter Receives FDA Clearance for DxC 500 AU Chemistry Analyzer, Expanding Portfolio with Proven Six Sigma Performance
    • 12.3.2. Siemens Healthineers launch Atellica CI Analyser for immunoassay testing
    • 12.3.3. Erba Introduces XL Range of Fully Automated Clinical Chemistry Systems at Medlab Middle East 2023
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Beckman Coulter, Inc. by Danaher Corporation
  • 3. Bio-Rad Laboratories, Inc.
  • 4. BioSystems Diagnostics Pvt. Ltd
  • 5. Cardinal Health, Inc
  • 6. Carolina Liquid Chemistries Corp.
  • 7. Chengdu Seamaty Technology Co., Ltd.
  • 8. DiaSys Diagnostic Systems GmbH
  • 9. ELITechGroup
  • 10. Erba Group
  • 11. F. Hoffmann-La Roche Ltd.
  • 12. Furuno Electric Co., Ltd.
  • 13. Horiba, Ltd.
  • 14. JEOL Ltd.
  • 15. Johnson & Johnson Services, Inc.
  • 16. Medica Corporation
  • 17. Medsource Ozone Biomedicals Pvt. Ltd.
  • 18. Mindray Medical International Limited
  • 19. Nova Biomedical Corporation
  • 20. Olympus Corporation
  • 21. Promea Therapeutics Pvt. Ltd.
  • 22. Randox Laboratories Ltd.
  • 23. Siemens AG
  • 24. Thermo Fisher Scientific, Inc.
  • 25. Trivitron Healthcare